These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2695219)

  • 1. Whole heart distribution of myocardial perfusion, metabolism and myocardial viability by positron emission tomography.
    Araujo LI; Maseri A
    Br Med Bull; 1989 Oct; 45(4):922-32. PubMed ID: 2695219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent twenty-four hour SPECT thallium-201 defects, plasma thallium-201 concentrations and PET metabolic viability.
    Brunken RC; Mody FV; Hawkins RA; Nienaber CA; Phelps ME; Schelbert HR
    Herz; 1994 Feb; 19(1):28-41. PubMed ID: 8150412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of tissue viability with fluorine-18-fluoro-2-deoxyglucose (FDG) and carbon-11-acetate PET imaging.
    Schröter G; Schneider-Eicke J; Schwaiger M
    Herz; 1994 Feb; 19(1):42-50. PubMed ID: 8150413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiac positron emission tomography--current status and future perspectives].
    Armbrecht JJ; Schelbert HR
    Z Kardiol; 1990 Mar; 79(3):151-60. PubMed ID: 2191506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of myocardial viability and coronary revascularization on clinical outcome and prognosis: a follow-up study of 161 patients with coronary heart disease].
    vom Dahl J; Altehoefer C; Büchin P; Sheehan FH; Schwarz ER; Koch KC; Schulz G; Uebis R; Schöndube F; Messmer BJ; Büll U; Hanrath P
    Z Kardiol; 1996 Nov; 85(11):868-81. PubMed ID: 9064949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Scintigraphy and positron emission tomography].
    Kaufmann PA
    Ther Umsch; 1997 Dec; 54(12):711-21. PubMed ID: 9465749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiologic applications of positron emission tomography].
    Schelbert H; Czernin J
    Wien Klin Wochenschr; 1994; 106(15):487-95. PubMed ID: 7941597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of global left ventricular function after bypass surgery in patients with severe left ventricular dysfunction. Impact of pre-operative myocardial function, perfusion, and metabolism.
    Pasquet A; Lauer MS; Williams MJ; Secknus MA; Lytle B; Marwick TH
    Eur Heart J; 2000 Jan; 21(2):125-36. PubMed ID: 10637086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential and limitations of Tc-99m sestamibi scintigraphy for the diagnosis of myocardial viability.
    Cornel JH; Arnese M; Forster T; Postma-Tjoa J; Reijs AE; Fioretti PM
    Herz; 1994 Feb; 19(1):19-27. PubMed ID: 8150411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relation between myocardial perfusion, myocardial necrosis and residual glucose metabolism as a vitality parameter in the post-ischemic myocardium following coronary reperfusion].
    Sochor H
    Acta Med Austriaca Suppl; 1989; 39():1-36. PubMed ID: 2787948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Positron emission tomography of the heart].
    Henze E
    Z Kardiol; 1987 May; 76(5):255-8. PubMed ID: 3497494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Scintigraphic evaluation of the ischemically damaged myocardium in patients with reduced left ventricular function. From clinical aspects to the cell].
    Schwaiger M; Egert S; Brosius F
    Z Kardiol; 1995; 84 Suppl 4():115-23. PubMed ID: 8585263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Positron emission tomography: principles and uses in cardiology].
    Porenta G; Czernin J; Schelbert H
    Wien Med Wochenschr; 1992; 142(15-16):358-66. PubMed ID: 1481541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessing myocardial perfusion with positron emission tomography].
    vom Dahl J
    Z Kardiol; 2001 Nov; 90(11):835-47. PubMed ID: 11771451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography in clinical cardiology.
    Brunken RC; Schelbert HR
    Cardiol Clin; 1989 Aug; 7(3):607-29. PubMed ID: 2670229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assessing myocardial viability in chronic myocardial infarct with 18F-fluoro-D-glucose positron emission tomography and 99mTc-MIBI SPECT].
    Schneider CA; Voth E; Theissen P; Wienhard K; Wagner R; Baer FM; Sechtem U; Schicha H
    Z Kardiol; 1994 Feb; 83(2):124-31. PubMed ID: 8165842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography for the assessment of myocardial viability.
    Schelbert HR
    Circulation; 1991 Sep; 84(3 Suppl):I122-31. PubMed ID: 1884478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Indications for clinical applications of positron emission tomography in cardiology. Position report of the PET Cardiology Study Group of the German Society of Nuclear Medicine and the Nuclear Cardiology Study Circle of the German Society of Cardiology].
    Z Kardiol; 1996 Jul; 85(7):453-68. PubMed ID: 8928543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The value of positron emission tomography (PET) in cardiologic diagnosis].
    Henze E
    Internist (Berl); 1990 May; 31(5):338-40. PubMed ID: 2380010
    [No Abstract]   [Full Text] [Related]  

  • 20. [Assessment of regional myocardial blood flow and energy metabolism].
    Yonekura Y; Senda M; Torizuka K
    J Cardiol Suppl; 1987; 15():65-9. PubMed ID: 3509973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.